{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:23:59Z","timestamp":1778682239514,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Auris Nasus Larynx"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.anl.2021.01.023","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T06:21:24Z","timestamp":1613370084000},"page":"885-889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The association between ear involvement and clinical features and prognosis in ANCA-associated vasculitis"],"prefix":"10.1016","volume":"48","author":[{"given":"Yuki","family":"Hosokawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichiro","family":"Suemori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiko","family":"Hamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Teraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ishizaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohito","family":"Hato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anl.2021.01.023_bib0001","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(85)91147-X","article-title":"The autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis","volume":"23","author":"van der Woude","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.anl.2021.01.023_bib0002","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1681\/ASN.2005101048","article-title":"Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies","volume":"17","author":"Jannette","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.anl.2021.01.023_bib0003","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1097\/MAO.0b013e31822558fd","article-title":"Otologic symptoms as initial manifestation of Wegener's granulomatosis: diagnostic dilemma","volume":"32","author":"Wierzbicka","year":"2011","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2021.01.023_bib0004","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/14397595.2016.1177926","article-title":"Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): a retrospective analysis of 235 patients from a nationwide survey in Japan","volume":"27","author":"Harabuchi","year":"2017","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.anl.2021.01.023_bib0005","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2332\/allergolint.14-RAI-0774","article-title":"Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis","volume":"63","author":"Yoshida","year":"2014","journal-title":"Allergol Int"},{"key":"10.1016\/j.anl.2021.01.023_bib0006","unstructured":"Harabuchi Y., Kishibe K., Tateyama K., Morita Y., Yoshida N., Okada M., et\u00a0al. Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society. Auris Nasus Larynx. in press."},{"key":"10.1016\/j.anl.2021.01.023_bib0007","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1097\/MAO.0000000000001563","article-title":"Comparison of localized and systemic otitis media with ANCA-associated vasculitis","volume":"38","author":"Okada","year":"2017","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2021.01.023_bib0008","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.anl.2018.05.011","article-title":"The treatment outcomes of rituximab for intractable otitis media with ANCA-associated vasculitis","volume":"46","author":"Okada","year":"2019","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2021.01.023_bib0009","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/MAO.0000000000001223","article-title":"Vestibular involvement in patients with otitis media with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"38","author":"Morita","year":"2017","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2021.01.023_bib0010","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jgf2.112","article-title":"Do you know otitis media with ANCA-associated vasculitis (OMAAV)?","volume":"18","author":"Hisata","year":"2017","journal-title":"J Gen Fam Med"},{"key":"10.1016\/j.anl.2021.01.023_bib0011","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.2169\/internalmedicine.8704-16","article-title":"Otitis media with ANCA-associated vasculitis: a new concept and the associated criteria","volume":"56","author":"Kobari","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.anl.2021.01.023_bib0012","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.anl.2017.12.007","article-title":"Cochlear implantation in patients with bilateral deafness caused by otitis media with ANCA-associated vasculitis (OMAAV): a report of four cases","volume":"45","author":"Watanabe","year":"2018","journal-title":"Auris Nasus Larynx"},{"key":"10.1016\/j.anl.2021.01.023_bib0013","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1097\/MAO.0000000000002081","article-title":"The diagnostic and clinical utility of the myeloperoxidase-DNA complex as a biomarker in otitis media with antineutrophil cytoplasmic antibody-associated vasculitis","volume":"40","author":"Morita","year":"2019","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.anl.2021.01.023_bib0014","unstructured":"Morita Y., Kitazawa M., Yagi C., Nonomura Y., Takahashi K., Yamagishi T., et\u00a0al. Tympanic membrane findings of otitis media with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV). Auris Nasus Larynx. in press."},{"issue":"29","key":"10.1016\/j.anl.2021.01.023_bib0015","first-page":"20","article-title":"Clinical practice guideline of the Japan research committee of the ministry of health, labour, and welfare for intractable vasculitis for the management of ANCA-associated vasculitis","volume":"2019","author":"Harigai","year":"2017","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.anl.2021.01.023_bib0016","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/14397595.2018.1500111","article-title":"Systematic review and meta-analysis for 2017 clinical practice guidelines of the japan research committee of the ministry of health, labour, and welfare for intractable vasculitis for the management of ANCA-associated vasculitis","volume":"29","author":"Nagasaka","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.anl.2021.01.023_bib0017","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10067-018-4372-z","article-title":"Incidence and risk factors of new-onset hypertrophic pachymeningitis in patients with anti-neutrophil antibody-associated vasculitis: using logistic regression and classification tree analysis","volume":"38","author":"Imafuku","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.anl.2021.01.023_bib0018","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1007\/s00405-018-5172-4","article-title":"Anti-neutrophil cytoplasmic antibody-associated hypertrophic cranial pachymeningitis and otitis media: a review of literature","volume":"275","author":"Peng","year":"2018","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.anl.2021.01.023_bib0019","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s10067-018-4019-0","article-title":"Ear, nose and throat involvement in granulomatosis with polyangiitis: how it presents and how it determined disease severity and long-term outcomes","volume":"37","author":"Felicetti","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.anl.2021.01.023_bib0020","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00296-014-3106-z","article-title":"Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan","volume":"35","author":"Ono","year":"2015","journal-title":"Rhematol Int"},{"key":"10.1016\/j.anl.2021.01.023_bib0021","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/rheumatology\/keu357","article-title":"Renal function and ear, nose, throat involvement in anti-neutrophil cytoplasmic antibody-associated vasculitis: prospective data from the European Vasculitis Society clinical trials","volume":"54","author":"Rahmattulla","year":"2015","journal-title":"Rheumatol"},{"key":"10.1016\/j.anl.2021.01.023_bib0022","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa020286","article-title":"A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies","volume":"349","author":"Jayne","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2021.01.023_bib0023","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/s10165-011-0525-5","article-title":"Severity-based treatment for Japanese patients with MPO-ANCA-associated vascolitis: the JMAAV study","volume":"22","author":"Ozaki","year":"2012","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.anl.2021.01.023_bib0024","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1404231","article-title":"Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis","volume":"371","author":"Guillevin","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anl.2021.01.023_bib0025","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/ki.2010.472","article-title":"New pathophysiological insights and treatment of ANCA-associated vasculitis","volume":"79","author":"Wilde","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.anl.2021.01.023_bib0026","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1212\/NXI.0000000000000615","article-title":"Peripheral neuropathy in antineutrophil cytoplasmic antibody-associated vasculitis: in sight from the DCVAS study","volume":"6","author":"Bischof","year":"2019","journal-title":"Neurol Neuroimmunol Neuroimflamm"},{"key":"10.1016\/j.anl.2021.01.023_bib0027","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10157-012-0651-1","article-title":"Current status of the treatment of microscopic polyangiitis and granulomatosis with polyangiitis in Japan","volume":"17","author":"Sugiyama","year":"2013","journal-title":"Clin Exp Nephrol"}],"container-title":["Auris Nasus Larynx"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814621000420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0385814621000420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T19:37:53Z","timestamp":1759952273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0385814621000420"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0385814621000420"],"URL":"https:\/\/doi.org\/10.1016\/j.anl.2021.01.023","relation":{},"ISSN":["0385-8146"],"issn-type":[{"value":"0385-8146","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between ear involvement and clinical features and prognosis in ANCA-associated vasculitis","name":"articletitle","label":"Article Title"},{"value":"Auris Nasus Larynx","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anl.2021.01.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Oto-Rhino-Laryngological Society of Japan Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}